Healthcare

spot_imgspot_img

Synthekine Appoints Susan M. Molineaux as CEO to Lead Next Phase of Oncology Innovation

Clinical-stage biotechnology company Synthekine has appointed Susan M. Molineaux, Ph.D. as its new Chief Executive Officer, marking a leadership transition as the company advances...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img